seems like the buying has now abated. Just sitting there at around $117.50. I've just sold my shares as I'm thinking that the profit-taking will now arise over the next couple of hours.
Hats off to phaseleg, the stupido, - it is now trading at $53.45. So the 180 shares are worth $9,621. You must be stupid stupid stupido.
Movantik, which has sales potential of $2 billion for AZN, is now expected to be given final FDA clearance in mid-September. If this occurs, Nektar would stand to gain around $545 million in milestone payments from AZN. Meanwhile, NKTR's finances have improved quite a bit.